@onclive.bsky.social📰 The @fda.gov MCGP advisory committee voted in favor of the premarket approval application for the Galleri MCED test for cancer screening in adults ages 50 years and older. #oncology
Full story on our site ➡️: www.onclive.com/view/fda-mcg...
@onclive.bsky.socialIn this commentary, Maurie Markman, MD, of @cityofhope.bsky.social, proposes a novel approach to the use of AI in oncology that may require discussion and modification of existing barriers. #oncology
Read the full story ➡️: www.onclive.com/view/positio...
@bd-angry.bsky.social
@bcc2026.bsky.socialAre you ready to share your latest breast cancer research?
Submit your abstract to BCC 2027 and share your research, and clinical insights with an international audience.
June 17–18, 2027
Zurich, Switzerland
@tfcril.bsky.socialToday marks World Cancer Reseach Day. The importance of fostering collaboration among #scientists, #patients & #institutions to drive breakthroughs in #oncology & post-cancer patient care is recognition of WCRD.
TFC is actively supporting ..
@jagranicancer.bsky.socialGet proper consultation and access to advanced treatment from a team of specialist doctors for cancer-related problems. Meet the specialists and get the right advice at the right time.
Visit - www.jagranihospital.in/services-bes...
#JagraniHospital #CancerTreatment #Oncology #Lucknow #Sandila
@hemehub.bsky.social🩸🔍 Today’s questions!
Swipe to see the answers and explanations!
#SmolderingMultipleMyeloma #SMM #MultipleMyeloma #Hematology #HemeOnc #Oncology #MedicalEducation #MedEd #HemeHub
@gmj-georgia.bsky.socialA landmark study has now mapped bacteria, viruses, and fungi living inside tumors across 33 cancer types—from gastrointestinal to hematologic malign… #Bacterialecosystems #Cancermicrobiome #Microbiotacancer #Oncology #Tumorbiology #Bacterialecosystems #Cancermicrobiome #Microbiotacancer #Oncolo…
@jimqualls.bsky.socialJanna & I ARE BOTH #THANKFUL this evening for good #Oncology reports from our world best Oncologists Dr Trevor Feinstein & Dr Erin Dunbar. We enjoyed late lunch at Mary Mac’s Tea Room to celebrate. #TakeCareOfYourself
@cureswithinreach.bsky.socialWe recently started funding an ongoing #oncology #repurposing #ClinicalTrial in solid organ cancer at @uchicagomedicine.bsky.social: Adding Lactulose to Immunotherapy to Improve Cancer Treatment Outcome led by Dr. Reid Shaw
www.cureswithinreach.org/2026/05/28/a...
@thebabaklab.bsky.socialA new study in Cell Chemical Biology explored how the mechanism driving oncogene overexpression can determine the effectiveness of protein degraders such as PROTACs.
Link in the comments 👇
#TargetedProteinDegradation #PROTAC #CancerResearch #DrugDiscovery #Oncology
@onclive.bsky.socialWATCH: @elmayermd.bsky.social, of @danafarber.bsky.social and @harvardmed.bsky.social, highlights the @fda.gov approval of camizestrant plus a CDK4/6 inhibitor for HR+, HER2–, emergent ESR1-mutated breast cancer. #bcsm #oncology
Read our coverage of the approval: www.onclive.com/view/fda-app...
@onclive.bsky.socialWATCH 🎥: @elmayermd.bsky.social, of @danafarber.bsky.social and @harvardmed.bsky.social, discusses the @fda.gov approval of camizestrant for emergent ESR1-mutated breast cancer. #bcsm #oncology
Full video ➡️: www.onclive.com/view/dr-maye...
@ontarget-podcast.bsky.socialMirna Jarosz, CEO of #LiquidCellDx, explains how her company's #liquidbiopsy captures information about the #tumormicroenvironment, providing critical treatment guidance.
🎧 Listen now → www.ontargetpodcast.com
#OnTarget #PrecisionMedicine #Oncology #Immunotherapy #CancerDiagnostics #AI
@onclive.bsky.socialWATCH 🎥: Shimoli Barot, MD, of @clevelandclinic.bsky.social, discusses PATINA data showing improved PFS with palbociclib-based maintenance in HR-positive, HER2-positive metastatic breast cancer. #bcsm #oncology
Full video 👀: www.onclive.com/view/dr-baro...
@onclive.bsky.socialWATCH 📺: Shimoli Barot, MD, of @clevelandclinic.bsky.social, considers how palbociclib-based maintenance could be sequenced with frontline T-DXd plus pertuzumab in HER2-positive metastatic breast cancer. #bcsm #oncology
Full video ➡️: www.onclive.com/view/dr-baro...
@onclive.bsky.social📈 The IDMC overseeing an ongoing phase 2 MRD translational study of IMNN-001 in newly diagnosed advanced ovarian cancer has recommended the trial continue without modification. #gyncsm #oncology
More insights ➡️: www.onclive.com/view/idmc-re...
@onclive.bsky.social📰 At the 2026 International Invasive Lobular Carcinoma Symposium, @ucsfcancer.bsky.social clinicians and researchers will share their experiences and insights about future treatment directions. #bcsm #oncology
Read more ➡️: www.onclive.com/view/ucsf-br...
@sroa-radonc.bsky.socialThe Mayo Clinic reported promising patient results for minibeam radiotherapy, which splits a standard beam into half-millimeter beamlets, creating high-dose "peaks" and low-dose "valleys" where healthy tissue can recover. shorturl.at/n2l4n #radiotherapy #oncology #tumors #sarcoma #skincancer
@nordrare.bsky.socialThis #RareCancerDay, NORD is sharing findings from a survey of oncologists we conducted with @medliveofficial.bsky.social.
What we found: 1 in 2 oncologists don't feel confident recognizing a rare #cancer.
Read our full findings: bit.ly/4cXKhgn
